108 studies found for:    "Hepatic encephalopathy"
Show Display Options
Rank Status Study
1 Completed Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Conditions: Hepatic Encephalopathy;   Minimal Hepatic Encephalopathy;   Cirrhosis
Interventions: Procedure: Vastus Muscle Biopsy;   Drug: LOLA or placebo;   Other: Cognitive assessment (PHES);   Other: Cognitive Assessement (Cogstate);   Other: blood and urine sampling;   Other: Nutritional assessment;   Other: MRI brain and spectroscopy;   Other: MRI leg cross section;   Other: Functional MRI (working memory and attention tasks)
2 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
3 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
4 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
5 Withdrawn Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Conditions: Hepatic Encephalopathy;   HE;   Cirrhosis;   Altered Mental Status;   AMS
Interventions: Drug: Lactulose;   Drug: Polyethylene Glycol 3350
6 Terminated
Has Results
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
7 Completed Neuromonitoring of Hepatic Encephalopathy
Conditions: Liver Failure, Acute;   Hepatic Encephalopathy
Intervention: Device: Molecular Adsorbent Recirculating System (MARS)
8 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
9 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
10 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
11 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
12 Completed AST-120 Used to Treat Mild Hepatic Encephalopathy
Condition: Mild Hepatic Encephalopathy
Intervention: Drug: AST-120
13 Recruiting Fecal Transplant in Recurrent Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Cirrhosis
Intervention: Biological: Fecal transplant
14 Recruiting The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
15 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
16 Completed Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Conditions: Minimal Hepatic Encephalopathy;   Hepatic Encephalopathy
Intervention: Drug: Lactulose
17 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
18 Completed Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: placebo
19 Completed Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
Conditions: Hepatic Cirrhosis;   Minimal Hepatic Encephalopathy
Interventions: Other: Auxiliary Treatment;   Dietary Supplement: Hyperproteic and fiber-rich diet;   Drug: Nitazoxanide
20 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years